# OnCo record sumitomo-pharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/sumitomo-pharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "sumitomo-pharma" ;
  schema:name "Sumitomo Pharma (Myovant)"@en ;
  schema:description "Sumitomo Pharma makes Orgovyx (relugolix), the first oral GnRH antagonist for prostate cancer."@en ;
  schema:url <https://onco.cc/companies/sumitomo-pharma/>, <https://www.sumitomo-pharma.com> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://www.sumitomo-pharma.com> ;
  schema:addressCountry "JP" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/hormonal/> ;
  onco:drugs <https://onco.cc/drugs/relugolix/>, <https://onco.cc/drugs/amrubicin/> ;
  onco:trials <https://onco.cc/trials/nct05862272/>, <https://onco.cc/trials/nct06526819/>, <https://onco.cc/trials/nct04988555/> .